Sanofi acquires 4.9% of Novavax shares for $70 million, doubling the latter's valuation to around $1.4 billion. This investment is part of a co-exclusive licensing agreement...
As for Pfizer-BioNTech, AI claims that it has supplied Sweden (10 million inhabitants), nine times more vaccines than all low-income countries combined. Of Moderna, the NGO...